Incidence of cervical high-grade squamous intraepithelial lesions in HIV-1-infected women with no history of cervical pathology: up to 17 years of follow-up.
Adult
Anti-HIV Agents
/ therapeutic use
Antiretroviral Therapy, Highly Active
/ methods
Female
Follow-Up Studies
HIV Infections
/ complications
Humans
Incidence
Medication Adherence
Middle Aged
Papillomavirus Infections
/ epidemiology
Retrospective Studies
Risk-Taking
Spain
/ epidemiology
Squamous Intraepithelial Lesions of the Cervix
/ epidemiology
Uterine Cervical Neoplasms
/ epidemiology
Uterine Cervical Dysplasia
/ epidemiology
Cervical squamous intraepithelial lesions
HIV
HPV
Journal
International journal of STD & AIDS
ISSN: 1758-1052
Titre abrégé: Int J STD AIDS
Pays: England
ID NLM: 9007917
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
pubmed:
2
9
2018
medline:
23
7
2019
entrez:
2
9
2018
Statut:
ppublish
Résumé
Currently, Papanicolaou smears are proposed at three-year intervals for cervical screening to all women living with HIV. The aim of this retrospective cohort study was to provide data on the incidence of cervical high-grade squamous intraepithelial lesions (HSIL) in cervical smear confirmed by histology in HIV-1-infected women (two consecutive normal Papanicolaou smears at baseline) after a long-term follow-up. Sixty-seven women (recruited between March 1999 and January 2003) were analyzed. The median period of follow-up was 13.2 years (range: 7.4-17.1 years) with a total of 583 Papanicolaou smears. Twenty-seven percent of these HIV-1-infected women had poorly-controlled HIV. Cumulative incidence of HSIL was 18% (12/67; 95%CI: 11-29%) of which one was an invasive squamous cell carcinoma and two were carcinoma in situ. These women had not been well-engaged with the annual Papanicolaou smear screening program and had poor adherence to antiretroviral therapy. Development of HSIL was associated with high-risk-HPV infection (OR: 14.9; 95%CI: 3.0, 75.1). At last Papanicolaou smear, prevalence of high-risk-HPV infection was 30% (20/66, 95%CI: 21-42%). In conclusion, the incidence of cervical HSIL in HIV-1-infected women with poor antiretroviral therapy adherence or poor immunological status reinforces the need to identify those HIV-1-infected women at risk of developing cervical cancer.
Identifiants
pubmed: 30170532
doi: 10.1177/0956462418792653
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM